Line probe assay (GenoType MTBDRplus) for first-line drug susceptibility testing detects mutations in which gene pair to identify isoniazid resistance?
- A rpoB and rrs genes
- B embB and ethA genes
- C pncA and gyrA genes
- D katG (S315T) and inhA promoter region mutations ✓
Explanation
The FL-LPA (GenoType MTBDRplus) detects isoniazid resistance through mutations in two genes: katG codon 315 (Ser→Thr, the most common, high-level INH resistance) and the inhA promoter region (low-level INH resistance, often associated with ethionamide cross-resistance). rpoB mutations indicate rifampicin resistance. embB detects ethambutol resistance; pncA detects pyrazinamide resistance; gyrA/gyrB detect fluoroquinolone resistance (detected on SL-LPA).
Reference: Ananthanarayan & Paniker's Textbook of Microbiology, 11th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.